Evaluating Genetic Modifiers of Cutaneous Neurofibromas in Adults with Neurofibromatosis Type 1

Launched by STANFORD UNIVERSITY · Jun 18, 2021

Keywords

ClinConnect Summary

This clinical trial is focused on understanding a condition called Neurofibromatosis Type 1 (NF1), which can cause skin growths known as neurofibromas. The researchers aim to collect genetic information from adults with NF1 to find out if certain genes are linked to how the disease shows up in different people. By doing this, they hope to improve future treatments and care for those affected by NF1.

To participate in this study, you need to be at least 40 years old and have been diagnosed with NF1, along with having at least one neurofibroma. If you decide to join, you will help researchers gather important information that could lead to better understanding and management of NF1. It's important that participants can understand the study details and are willing to follow through with all study requirements. This trial is currently looking for volunteers, and all genders are welcome to participate.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Age 40 or older.
• • NF type 1 diagnosed using clinical criteria.
• • At least one neurofibroma present at time of enrollment.
• • Patient able to read and understand consent form (or equivalent translation) and able to give consent.
• • Patient able and willing to complete all study procedures.